Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/04/2003US20030224477 Comprises nucleotide sequences associated with expression vectors for improving gene transfer and expression in cells
12/04/2003US20030224476 Enhancing transglutaminase reactivity for use in food processing and flavor improvement
12/04/2003US20030224463 Using aberrant nucleotide sequence repair to diagnose and determine cancer predisposition
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224460 Novel compositions and methods for lymphoma and leukemia
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224456 Identifying modulators which act on a signal transducer and activator of transcription (STAT) protein; for diagnosing and treating cancers
12/04/2003US20030224454 Human solute carrier family 7, member 11 (hSLC7A11)
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224451 Novel protein related to melanoma-inhibiting protein and uses thereof
12/04/2003US20030224450 Comprises nucleotide sequences coding transient receptor potential channel (TRP) for use in diagnosis and treatment of osteoporosis, nervous system, kidney and cancer disorders
12/04/2003US20030224442 Comprises nucleotide sequences coding g-protein coupled receptor for use in treatment of anxiety, depression, obsessive-compulsive, schizophrenia autism, migraine, emesis, alcoholism and neurodegenerative disorders
12/04/2003US20030224440 Vomeronasal organ nucleotide sequences for use in diagnosis and treatment of sexual disorders
12/04/2003US20030224438 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
12/04/2003US20030224431 Comprises nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development
12/04/2003US20030224429 DNA sequence encoding a human imidazoline receptor and method for cloning the same
12/04/2003US20030224427 Comprises DNAX interferon-like receptor subunit (DIRS) polypeptide for use in diagnosis and treatment of inflammation and blood disorders
12/04/2003US20030224426 Human G-protein chemokine receptor HSATU68
12/04/2003US20030224425 ACRP30-like polynucleotides, polypeptides, and antibodies
12/04/2003US20030224424 PHOX2B polymorphisms as hirschsprung's disease diagnostic markers and methods based thereon
12/04/2003US20030224423 Method of testing for allergic diseases
12/04/2003US20030224417 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224412 Structurally biased random peptide libraries based on different scaffolds
12/04/2003US20030224410 Selecting nucleic acid sequences coding ligand and receptor molecules capable of specific binding to each other for use in epitope mapping; rational drug design
12/04/2003US20030224406 MBCATs as modifiers of the beta-catenin pathway and methods of use
12/04/2003US20030224405 Transcriptional regulator
12/04/2003US20030224402 Progression suppressed gene 13 (PSGen 13) and uses thereof
12/04/2003US20030224401 Proteins for helicobacter diagnosis
12/04/2003US20030224400 Novel human G-protein coupled receptor, HGPRBMY11, and variants thereof
12/04/2003US20030224393 Comprise nucleotide sequences coding prostaglandin E receptor for diagnosis and treatment or arteriosclerosis/cardiovascular diseases
12/04/2003US20030224386 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/04/2003US20030224381 Delta-erythroid kruppel-like factors and methods of use
12/04/2003US20030224379 Novel nucleic acids and polypeptides
12/04/2003US20030224376 Novel human transferase family members and uses thereof
12/04/2003US20030224367 Novel polypeptides and nucleic acids encoding same
12/04/2003US20030224362 Diagnosing alcoholism using presence of mutation in neuropeptide y gene; drug abuse; restriction fragment length polymorphisms; immunoassay
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224355 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (alpha), HNF-1beta and HNF-4alpha
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224350 Elimination of endogenous porcine retrovirus
12/04/2003US20030224343 Kappa-PVIIA-related conotoxins as organ protectants
12/04/2003US20030224335 Crystal structures of cellular molecules that play important roles in immunity, phosphorylation events, and disease initiation mechanisms.
12/04/2003US20030224052 Water soluble proteins (especially hair) and covalent interprotein crosslinks other than disulfide crosslinks.
12/04/2003US20030224036 Containing epitope polypeptides, amino acid sequences, a immunotherapy for treating cancer; cancer vaccines
12/04/2003US20030224021 Methods of using epitope peptides of human pathogens
12/04/2003US20030224016 Transport peptides such as C-terminal Erns peptide and analogues thereof
12/04/2003US20030224015 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
12/04/2003US20030224014 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
12/04/2003US20030224013 Methods for protection against Coccidioides spp. infection using Coccidioides spp. urea amidohydrolase (Ure) protein
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224004 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030224003 Administering to a mammal a preparation containing a portion of the amino acid sequence of mature adenylate cyclase of a second Bordetella species for immunizing the mammal against infection by a first Bordetella species
12/04/2003US20030223997 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
12/04/2003US20030223996 Analyzing the level of B lymphocte stimulator (BLyS) expression in a sample of an individual using antibodies, comparing the level of BLyS assayed in biological sample with a standard level of BLyS expresion in normal sample
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223993 Novel steroid-activated nuclear receptors and uses therefor
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223987 Immunodeficiency recombinant poxvirus
12/04/2003US20030223977 Novel small proteins which bind cathepsin G have been identified. These are useful as inhibitors of excessive cathepsin G activity in patients.
12/04/2003US20030223975 Based on the discovery that a Y-box protein binding site is present as a transcription enhancer sequence in the promoter region situated upstream (i.e., 5' to) of the human PTP1B gene. This site, situated at nucleotides -155 through -132 of
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030223971 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
12/04/2003US20030223970 Methods and compounds for prevention of graft rejection
12/04/2003US20030223967 Expression constructs encoding the tumor suppressor p53 for the prevention or treatment of vascular stenosis caused by vascular smooth muscle cell (VSMC) proliferation and/or migration in response to vascular trauma. This p53 therapy
12/04/2003US20030223965 Bone generation by gene therapy
12/04/2003US20030223964 Efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the
12/04/2003US20030223961 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
12/04/2003US20030222461 Anti-panic opening system for doors
12/04/2003CA2694419A1 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/04/2003CA2513388A1 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003CA2497091A1 Adiponectin-knoucout nonhuman animal
12/04/2003CA2490542A1 Fas peptide mimetics and uses thereof
12/04/2003CA2489145A1 Insulin-sensitizing agent
12/04/2003CA2487811A1 Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2487419A1 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
12/04/2003CA2487351A1 Export and modification of (poly)peptides in the lantibiotic way
12/04/2003CA2487283A1 Method for assembling sub units into capsoides
12/04/2003CA2487269A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003CA2487246A1 Novel uses of cephaibols
12/04/2003CA2487243A1 Transformed fungi for production of recombinant proteins
12/04/2003CA2487112A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003CA2486967A1 Cardiolipin compositions their methods of preparation and use
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486578A1 Detection of secreted polypeptides
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003CA2486218A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2486113A1 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003CA2485976A1 Increased delivery of a nucleic acid construct in vivo by the poly-l-glutamate (plg) system
12/04/2003CA2485837A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485835A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485829A1 Methods and constructs for high yield expression of clostripain
12/04/2003CA2485816A1 Vaccines
12/04/2003CA2485737A1 Polypeptide cleavage process
12/04/2003CA2485733A1 Vaccines
12/04/2003CA2485703A1 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
12/04/2003CA2485701A1 Method for enzymatic production of glp-1 (7-36) amide peptides
12/04/2003CA2485695A1 Method for universal enzymatic production of bioactive peptides
1 ... 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 ... 2916